MTNB - Matinas BioPharma Holdings, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.87 -0.03 (-3.34%) --- --- 0.0 (0.0%) --- -0.03 (-3.34%) --- ---

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.03
Diluted EPS:
-1.03
Basic P/E:
-0.8155
Diluted P/E:
-0.8155
RSI(14) 1m:
0.0
VWAP:
0.84
RVol:

Events

Period Kind Movement Occurred At

Related News